HIV contributed to the resurgence of tuberculosis in the 1980s and 1990s in the United States. Globally it contributes mightily to the problem of tuberculosis(TB) in developing countries (Geiter, 2001) . It is estimated that nearly onethird of the 40 million people with HIV/AIDS worldwide are coinfected with TB (WHO, 2007) . TB coinfection with HIV has been called the "deadly intersection" because of the synergistic relationship between the organisms. HIV increases the likelihood of acquiring TB infection and is the single most important risk factor for progression from latent tuberculosis infection (LTBI) to active tuberculosis disease (Greiter, 2001) . This brief global view of TB/HIV coinfection paints, in stark terms, what is at stake for patients, for prevention and for control of TB.
In Virginia, the epidemiology of TB/HIV coinfection is intimately bound to the populations at higher risk for TB: US-born African Americans and foreign-born residents from countries with high prevalence of TB or high prevalence of TB and HIV.
Virginia is a medium TB incidence state and is ranked ninth in the nation in 2006, with 332 cases reported. U.S.-born African American residents of Virginia are six times more likely to have TB than White U.S.-born residents. In 2000, foreign-born TB cases surpassed U.S.-born cases for the first time and have remained a majority of the cases in each year since. By 2006, 70% of Virginia TB cases occurred among the foreign-born. TB/HIV Coinfection: Virginia (N=176) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) HIV is the most important known risk factor for progression from latent tuberculosis infection to tuberculosis disease (CDC, 2007) .
Persons with TB/HIV coinfection are five times more likely to die during anti-TB treatment than patients not infected with HIV (CDC, 2007).
All HIV patients should be screened for tuberculosis disease and latent tuberculosis infection and all TB patients should be tested for HIV infection (CDC, 2006) .
cases. Eighty-nine percent of the cases were aged 25 to 64, with one percent of the cases reported among those 14 and under and only three percent reported among people sixty-five and older. Across all cases 66% were Black, 17% Hispanic, 12% White and five percent occurred among Asian/Pacific Islanders. Figure 1 illustrates the shift from USborn to foreign-born cases of TB/HIV coinfection in the last few years. For this time period, 48% of the cases were reported among the foreign-born.
In the United States, for the period 2000 to 2004, TB/HIV coinfection ranged from zero to 23% of TB cases reported (Figure 2 .) In Virginia, for that period, 5.7% of TB cases had HIV coinfection.
Test, Screen, Treat
•Routine screening of HIV patients for tuberculosis disease and infection is recommended.
•For persons with HIV a tuberculin reaction of greater than or equal to 5 mm is classified as positive.
•HIV patients with a positive skin test should be evaluated for active disease.
•HIV patients with a positive tuberculin skin test should evaluated for treatment of latent tuberculosis infection.
Source: OTIS, National Tuberculosis Surveillance System, CDC, 2004 Critical Clinical Issues with TB and HIV coinfection
•Atypical presentation of TB.
•Drug-drug interactions.
•Treatment regimes for TB are different when patients have low CD4 counts.
See Iseman (2000) for more information.
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